Chrome Extension
WeChat Mini Program
Use on ChatGLM

Exploring Clinical Subgroups of Participants with Major Depressive Disorder That May Benefit from Adjunctive Minocycline Treatment

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College...(2024)SCI 4区

Hosp Clin Barcelona | Deakin Univ | Univ Melbourne | Univ Sydney

Cited 0|Views70
Abstract
Objective:: To explore illness-related factors in patients with major depressive disorder (MDD) recipients of adjunctive minocycline (200 mg/day) treatment. The analysis included participants experiencing MDD from a 12-week, double blind, placebo-controlled, randomized clinical trial (RCT). Methods:: This is a sub-analysis of a RCT of all 71 participants who took part in the trial. The impact of illness chronicity (illness duration and number of depressive episodes), systemic illness (endocrine, cardiovascular and obesity), adverse effects and minocycline were evaluated as change from baseline to endpoint (12-week) using ANCOVA. Results:: There was a consistent but statistically non-significant trend on all outcomes in favour of the use of adjunctive minocycline for participants without systemic illness, less illness chronicity, and fewer adverse effects. Conclusion:: Understanding the relationship between MDD and illness chronicity, comorbid systemic illness, and adverse effects, can potentially better characterise those individuals who are more likely to respond to adjunctive anti-inflammatory medications.
More
Translated text
Key words
Minocycline,Depression,Treatment,Clinical trial,Theragnostic,Inflammation
求助PDF
上传PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Upload PDF to Generate Summary
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Related Papers
2003

被引用893 | 浏览

M HAMILTON
1959

被引用12892 | 浏览

Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:本研究探讨了在患有重度抑郁症(MDD)的患者中,基于疾病相关因素识别可能从辅助性米诺环素治疗中受益的临床亚组。

方法】:通过对参与12周双盲、安慰剂对照、随机临床试验(RCT)的71名MDD患者的子分析,评估疾病慢性(疾病持续时间和抑郁发作次数)、系统性疾病(内分泌、心血管和肥胖)、不良影响以及米诺环素的影响。

实验】:使用ANCOVA分析基线到终点(12周)的变化,结果显示对于没有系统性疾病、疾病慢性程度较低和不良影响较少的参与者,辅助性米诺环素治疗呈现一致但统计上非显著的积极趋势。